Armata Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 02/11/2025 | 234,119 | $433,120 | 3.92% | 0.65% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 106,789 | $197,622 | -0.26% | 0.30% |
| EDGEWOOD MANAGEMENT LLC | 02/13/2025 | 100,000 | $185,000 | 0.00% | 0.28% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 69,682 | $128,912 | -7.56% | 0.19% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 49,788 | $92,108 | 67.15% | 0.14% |
| STATE STREET CORP | 02/14/2025 | 40,300 | $74,555 | 0.00% | 0.11% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 40,291 | $74,538 | -13.35% | 0.11% |
| SEACREST WEALTH MANAGEMENT, LLC | 01/14/2025 | 34,954 | $64,665 | 0.00% | 0.10% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 23,625 | $43,706 | -0.75% | 0.07% |
| CAPTRUST FINANCIAL ADVISORS | 02/14/2025 | 13,140 | $24,309 | 0.00% | 0.04% |
| GROUP ONE TRADING, L.P. | 02/14/2025 | 11,614 | $21,486 | -42.83% | 0.03% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 10,300 | $19,055 | 0.00% | 0.03% |
| UBS GROUP AG | 02/14/2025 | 6,313 | $11,679 | 167.84% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 3,312 | $6,127 | 65.19% | 0.01% |
| TRIFECTA CAPITAL ADVISORS, LLC | 02/04/2025 | 714 | $1,321 | 0.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 02/11/2025 | 571 | $1,056 | 0.00% | 0.00% |
| SALEM INVESTMENT COUNSELORS INC | 01/13/2025 | 100 | $185 | 0.00% | 0.00% |
| MAI CAPITAL MANAGEMENT | 02/14/2025 | 71 | $132 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 02/12/2025 | 25 | $46 | -3.85% | 0.00% |
| 02/06/2025 | 3 | $6 | 100.00% | 0.00% | |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 1 | $1 | 0.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Armata Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 25 institutional investors and hedge funds held shares of Armata Pharmaceuticals, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 234,119
GEODE CAPITAL MANAGEMENT, LLC: 106,789
EDGEWOOD MANAGEMENT LLC: 100,000
BRIDGEWAY CAPITAL MANAGEMENT, LLC: 69,682
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 49,788
STATE STREET CORP: 40,300
3.84% of Armata Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.42 M shares in the last 24 months. This purchase volume represents approximately $2.97 M in transactions.